OHSU Awarded $5.8 Million to Expand Health Information Technology Education
Thursday, April 29, 2010 (109 reads)
Portland, OR April 7, 2010 - Oregon Health & Science University has been
awarded $5.8 million in American Recovery and Reinvestment Act (ARRA)
funds to advance the widespread adoption and meaningful use of health
information technology (HIT) by educating professionals to work in this
rapidly growing field.
Read More |  |
|
|
|
|
|
FDA Grants DesignMedix Orphan Drug Designation For Malaria Drug
Monday, April 12, 2010 (122 reads)
Portland, Ore., (April 9, 2010) —DesignMedix, Inc., a Portland, Oregon drug development company, was granted Orphan Drug status for its lead malaria RCQ drug candidate. The designation by the U.S. Food and Drug Administration (FDA) places the program in a preferred status for regulatory review based on its use for treating malaria.
Read More | |
|
Genentech opens in Hillsboro, fueling Oregon's biotech aspirations
Wednesday, April 07, 2010 (118 reads)
Genentech's $400 million factory and distribution center formally opens Tuesday in
Hillsboro. The company has 250 working at the site now, putting the
factory through its paces as the company works to win federal approval
for full-scale production of Genentech's signature cancer drugs.
April 05, 2010, 8:12PM
Read More | |
|
 |
|
|